Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP -825 NDA
Allot CloudTrends Report Finds CSPs are Leveraging the Experience of Cloud Applications like Microsoft Office 365 and Lync
Avcorp announces 2014 Third Quarter Financial Results
OptiNose Announces Publication of Pivotal Phase III Results for Investigational Migraine Treatment Developed by OptiNose Using Bi-Directional™ Breath Powered™ Technology
Allot Communications Appoints Shmuel Arvatz as New Chief Financial Officer
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may ...